BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:55 PM
 | 
Oct 19, 2009
 |  BC Extra  |  Company News

Rituxan sBLA gets complete response, FDA cites PML

Genentech Inc. and Biogen Idec Inc. (NASDAQ:BIIB) said they received a complete response letter from FDA for an sBLA for Rituxan rituximab plus methotrexate to treat...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >